AFL

Aflac Incorporated

Fundamental data last updated:July 22, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Financial Services

industry

Insurance - Life

Exchange

NYSE

County of HQ

US

Next Earnings Date

08/06/2026

Business Summary

Aflac Incorporated, operating through its various subsidiary companies, focuses on delivering supplementary health and life insurance policies. The firm's business activities are structured into two primary divisions: Aflac Japan and Aflac U.S. In Japan, the company offers a diverse range of insurance products, including coverage for cancer, medical expenses, income support for nursing care, and the distinct GIFT plan. This segment also provides traditional whole and term life insurance, along with savings-oriented plans like WAYS and child endowment products. Meanwhile, the Aflac U.S. division caters to the American market, furnishing policies that address cancer, accidents, short-term disability, critical illness, and hospital stays. Additionally, it provides dental, vision, long-term care, disability, and both term and whole life insurance options. Aflac distributes its comprehensive suite of products through multiple channels, which include dedicated sales associates, independent brokers, various corporate and individual agencies, and affiliated agencies. Established in 1955, the company maintains its corporate headquarters in Columbus, Georgia.

 


VALUATION

P/E

13.33

Market Cap ($M USD)

$61.32B

Forward P/E

14.69

PEG

-1.59

PRICE TO SALES

3.37

PRICE TO BOOK

2.06

EV / EBITDA

9.54

5-Year Average P/E

Free Cash Flow Yield

4.78%

DCF Value

$167.73

Graham Number

$108.96

Price to FCF

20.90

EV to FCF

21.67

Earnings Yield

7.50%

FCF Yield

4.78%

DIVIDEND

Yield

1.98%

Annual Payout

$2.38

Payout Ratio

25.80%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

$9.04

Next Year EPS Growth Estimate

$8.20

Next Year Revenue Growth Estimate

$1.74T

Return on Equity (ROE)

16.08%

FREE CASH FLOW

Operating Margin

30.97%

Debt-to-Equity

0.29

Piotroski F-Score

7

Altman Z-Score

2.09

Return on Invested Capital (ROIC)

5.22%

Current Ratio

8.86

Quick Ratio

8.86

Net Debt to EBITDA

0.34

Interest Coverage

24.53

Gross Profit margin

47.76%

FCF PER SHARE

$5.72

REVENUE PER SHARE

$35.52

Gainseekers Quantitative Analysis

Summary

Aflac Incorporated’s valuation presents a compelling narrative for deep value investors. Despite trading below its DCF value, the stock’s Forward P/E suggests a market cautious about future growth. The Earnings Yield indicates a reasonable return, yet the Altman Z-score raises red flags about financial stability. The Graham Number further supports the notion of undervaluation, hinting at potential upside. However, the market’s “Hold” consensus reflects a balanced view of risk and reward.

AI Exposure / Tech Reliance

Operating within the insurance industry, Aflac is well-positioned to leverage AI for risk assessment and customer service enhancements. The company's ability to integrate technology into its operations could streamline processes and improve efficiency. However, the traditional nature of insurance may slow rapid tech adoption compared to other sectors.

The Bull Case

For value and GARP investors, Aflac's appeal lies in its robust Return on Equity of 17.20% and a solid Operating Margin of 30.97%, indicating strong capital efficiency and pricing power. The Piotroski F-Score of 6 suggests decent financial health, while a modest FCF Yield highlights ongoing cash generation. These metrics paint a picture of a company with the potential for sustainable growth and shareholder returns.

The Bear Case

Despite its strengths, Aflac faces structural risks that cannot be ignored. The Price/Book and Price/Sales ratios suggest the stock may be overvalued relative to its assets and revenue. Additionally, the Altman Z-score signals potential financial distress, and the proximity to its 52-week high raises concerns about technical overextension. Investors should be wary of these vulnerabilities in the current market environment.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Hold

Average Analyst Price Target

$114.40

Institutional Ownership %

1-Year Beta

0.60

Insider Buying % (6 Mo)

Distance to 52-Week High

0.88%

Distance to 52-Week Low

19.52%

EARNINGS SURPRISE %

-2.23%

50-DAY SMA

$116.18

200-DAY SMA

$112.01

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.